| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $64.2M | +66.3% |
| SG&A Expense | $17.2M | +17.6% |
| Operating Income | -$81.4M | -52.9% |
| Pre-tax Income | -$75.5M | -46.6% |
| Income Tax | $56K | +124.0% |
| Net Income | -$75.5M | -46.6% |
| EPS (Basic) | -$2.87 | -36.7% |
| EPS (Diluted) | -$2.87 | -36.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.5M | +4.9% |
| Short-term Investments | $98.9M | -7.4% |
| Current Assets | $124.2M | -5.5% |
| Total Assets | $127.4M | -5.8% |
| Current Liabilities | $17.6M | +126.6% |
| Total Liabilities | $18.0M | +109.9% |
| Stockholders' Equity | $109.5M | -13.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$56.8M | -45.1% |
| Capital Expenditures | $142K | -27.2% |
| Investing Cash Flow | $11.9M | +71.5% |
| Financing Cash Flow | $46.0M | — |
| Free Cash Flow | -$56.9M | -44.8% |